Related Experiment Videos
Altered expression of ALDP in X-linked adrenoleukodystrophy
P A Watkins1, S J Gould, M A Smith
1Kennedy Krieger Research Institute, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
American Journal of Human Genetics
|August 1, 1995
Summary
X-linked adrenoleukodystrophy (ALD) is a neurodegenerative disease. A new antibody reveals that most ALD patients lack the ALDP protein, with mutations impacting its stability or localization.
Area of Science:
- Biochemistry
- Genetics
- Cell Biology
Background:
- X-linked adrenoleukodystrophy (ALD) is a neurodegenerative disorder characterized by elevated very long-chain fatty acids.
- The ALD gene product (ALDP) is an ATP-binding cassette transporter, not directly involved in fatty acid metabolism.
Purpose of the Study:
- To investigate the subcellular distribution and abundance of ALDP in ALD patients using a novel antibody.
- To understand the mechanism of ALDP dysfunction in ALD pathogenesis.
Main Methods:
- Generated a specific antibody against ALDP.
- Utilized indirect immunofluorescence to detect ALDP in skin fibroblasts from normal individuals and ALD patients.
- Analyzed ALD gene mutations in patients.
Main Results:
- The antibody detected ALDP in peroxisomes of normal fibroblasts.
- 69% of ALD patients showed no detectable ALDP immunoreactivity.
- Deletion or frameshift mutations resulted in ALDP absence; missense mutations sometimes led to immunonegativity, suggesting instability or mislocalization.
- No correlation was found between ALDP immunofluorescence patterns and clinical phenotypes.
Conclusions:
- The study provides insights into ALDP protein levels and localization in ALD.
- Missense mutations can affect ALDP stability or localization, contributing to disease.
- This approach may aid in assessing heterozygote status in female relatives.